Details

NameSymbolSector
VISTA PHARMACEUTICALS LTD.VISTAPHPharmaceuticals
Open
10.27
High
11.17
Low
10.27
Close
10.97
Volume
1759
Exchange
bse
Time
14/08

Outlook

Score:  

3

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Vista Pharmaceuticals is  
Opening Marubozu
Estimated Stoploss of Vista Pharmaceuticals is ₹  
10.27
Vista Pharmaceuticals has a  
Bullishℹ
 pattern. 
Formation of  
Opening Marubozu
 candle pattern indicates Vista Pharmaceuticals has chances of  
Continuationℹ
 of the current trend. 

Trend

Vista Pharmaceuticals is in  
Sideways trendℹ
. 
Price of Vista Pharmaceuticals is  
Upℹ
 by  

1.01

%. 
Target
Buy @ 

10.19

Sell @ 

11.61

Volume

The trade volumes of Vista Pharmaceuticals have become  
Deficientℹ
Though the volume trend for Vista Pharmaceuticals appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Vista Pharmaceuticals is  

Down

 by  

80.28

% 

Valuation

The current market price of Vista Pharmaceuticals is  
Undervaluedℹ

Financials

Balance
The balance sheet of Vista Pharmaceuticals is:  

Balanced

Cashflow
Vista Pharmaceuticals has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

42.86% i.e. ₹ 6cr spent in operatingℹ
0% in investingℹ
57.14% i.e. ₹ 8cr earned in financingℹ
0% in otherℹ
Vista Pharmaceuticals has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

44.44% i.e. ₹ 4cr spent in operatingℹ
0% in investingℹ
55.56% i.e. ₹ 5cr earned in financingℹ
0% in otherℹ
Income
The income of Vista Pharmaceuticals is  

₹ 1cr

 and  

Loss

 is :  

₹ 1cr

(*Jun 2025)

Vista Pharmaceuticals Losses increased by:  

0

% and Income is Down by:  

66.67

% 

(*Jun 2025)

The income of Vista Pharmaceuticals is  

₹ 3cr

 and  

Loss

 is :  

₹ 1cr

(*Mar 2025)

Vista Pharmaceuticals Losses increased by:  

0

% and Income is Up by:  

50

% 

(*Mar 2025)

The income of Vista Pharmaceuticals is  

₹ 2cr

 and  

Loss

 is :  

₹ 1cr

(*Dec 2024)

Vista Pharmaceuticals Losses increased by:  

100

% and Income is Up by:  

0

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.